These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc. Nass SJ; Dickson RB Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860 [TBL] [Abstract][Full Text] [Related]
23. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases. Alexandrow MG; Moses HL J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150 [TBL] [Abstract][Full Text] [Related]
24. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest. Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591 [TBL] [Abstract][Full Text] [Related]
25. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering. Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487 [TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells. Hu X; Cress WD; Zhong Q; Zuckerman KS Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571 [TBL] [Abstract][Full Text] [Related]
27. Effect of transforming growth factor-beta on early and late activation events in human T cells. Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460 [TBL] [Abstract][Full Text] [Related]
28. The retinoblastoma gene product is reversibly dephosphorylated and bound in the nucleus in S and G2 phases during hypoxic stress. Amellem O; Stokke T; Sandvik JA; Pettersen EO Exp Cell Res; 1996 Aug; 227(1):106-15. PubMed ID: 8806457 [TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178 [TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor alpha interferes with the cell cycle of normal and papillomavirus-immortalized human keratinocytes. Vieira KB; Goldstein DJ; Villa LL Cancer Res; 1996 May; 56(10):2452-7. PubMed ID: 8625327 [TBL] [Abstract][Full Text] [Related]
31. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth. Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988 [TBL] [Abstract][Full Text] [Related]
32. c-myc and pRB: role in TGF-beta 1 inhibition of keratinocyte proliferation. Murphy CS; Pietenpol JA; Münger K; Howley PM; Moses HL Cold Spring Harb Symp Quant Biol; 1991; 56():129-35. PubMed ID: 1819482 [TBL] [Abstract][Full Text] [Related]
33. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta. Matsumoto K; Hashimoto K; Hashiro M; Yoshimasa H; Yoshikawa K J Cell Physiol; 1990 Oct; 145(1):95-101. PubMed ID: 2211846 [TBL] [Abstract][Full Text] [Related]
34. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1. Braun L; Dürst M; Mikumo R; Gruppuso P Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761 [TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Piazza GA; Ritter JL; Baracka CA Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633 [TBL] [Abstract][Full Text] [Related]
37. The pRb-related protein p130 is a possible effector of transforming growth factor beta 1 induced cell cycle arrest in keratinocytes. Herzinger T; Wolf DA; Eick D; Kind P Oncogene; 1995 Jun; 10(11):2079-84. PubMed ID: 7784052 [TBL] [Abstract][Full Text] [Related]
38. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. Golay J; Cusmano G; Introna M J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of hepatocyte DNA synthesis by transforming growth factor beta 1 and cyclic AMP: effect immediately before the G1/S border. Thoresen GH; Refsnes M; Christoffersen T Cancer Res; 1992 Jul; 52(13):3598-603. PubMed ID: 1319826 [TBL] [Abstract][Full Text] [Related]
40. Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product. Pietenpol JA; Münger K; Howley PM; Stein RW; Moses HL Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10227-31. PubMed ID: 1946442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]